Works matching IS 10870156 AND DT 2014 AND VI 32 AND IP 10
Results: 41
Insomniacs get new mechanism sleep drug Belsomra.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 10, p. 968, doi. 10.1038/nbt1014-968
- By:
- Publication type:
- Article
First Rounders Podcast: Mary Tanner.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 10, p. 978, doi. 10.1038/nbt.3032
- Publication type:
- Article
Novartis wades into stem cell therapies.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 10, p. 969, doi. 10.1038/nbt1014-969e
- Publication type:
- Article
Generation of the epicardial lineage from human pluripotent stem cells.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 10, p. 1026, doi. 10.1038/nbt.3002
- By:
- Publication type:
- Article
How deep is enough in single-cell RNA-seq?
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 10, p. 1005, doi. 10.1038/nbt.3039
- By:
- Publication type:
- Article
BGI, Imperial and Waters.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 10, p. 969, doi. 10.1038/nbt1014-969b
- Publication type:
- Article
Recent patent applications in three-dimensional cell culture.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 10, p. 1004, doi. 10.1038/nbt.3047
- Publication type:
- Article
Student-led startup Covagen snapped up by J&J.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 10, p. 965, doi. 10.1038/nbt1014-965c
- Publication type:
- Article
Global analysis of protein structural changes in complex proteomes.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 10, p. 1036, doi. 10.1038/nbt.2999
- By:
- Publication type:
- Article
Gaucher's disease oral therapy gets nod from FDA.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 10, p. 970, doi. 10.1038/nbt1014-970
- By:
- Publication type:
- Article
People.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 10, p. 1066, doi. 10.1038/nbt.3046
- Publication type:
- Article
The scope of patent protection for gene technology in China.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 10, p. 1001, doi. 10.1038/nbt.3031
- By:
- Publication type:
- Article
Self-hydrolyzing maleimides improve the stability and pharmacological properties of antibody-drug conjugates.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 10, p. 1059, doi. 10.1038/nbt.2968
- By:
- Publication type:
- Article
Apple moves on health, drug developers shift into smart gear.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 10, p. 965, doi. 10.1038/nbt1014-965a
- By:
- Publication type:
- Article
NRC revisits GE crop risks.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 10, p. 969, doi. 10.1038/nbt1014-969a
- By:
- Publication type:
- Article
Research Highlights.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 10, p. 1010, doi. 10.1038/nbt.3042
- Publication type:
- Article
Restoring the pharmaceutical industry's reputation.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 10, p. 983, doi. 10.1038/nbt.3036
- By:
- Publication type:
- Article
Exelixis slashes 70% of staff.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 10, p. 966, doi. 10.1038/nbt1014-966c
- Publication type:
- Article
Beat beer spoilers.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 10, p. 969, doi. 10.1038/nbt1014-969c
- Publication type:
- Article
Around the world in a month.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 10, p. 974, doi. 10.1038/nbt1014-974
- Publication type:
- Article
Corporate venture capital and Cambridge.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 10, p. 975, doi. 10.1038/nbt.3029
- By:
- Publication type:
- Article
Development of the clinical next-generation sequencing industry in a shifting policy climate.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 10, p. 980, doi. 10.1038/nbt.3030
- By:
- Publication type:
- Article
First stem cell-derived islets in humans.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 10, p. 969, doi. 10.1038/nbt1014-969d
- Publication type:
- Article
Time to deliver.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 10, p. 961, doi. 10.1038/nbt.3045
- Publication type:
- Article
Pharma partners with efforts to pool patient genotype and phenotype data.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 10, p. 967, doi. 10.1038/nbt1014-967
- By:
- Publication type:
- Article
Targeted sequencing by proximity ligation for comprehensive variant detection and local haplotyping.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 10, p. 1019, doi. 10.1038/nbt.2959
- By:
- Publication type:
- Article
Low-coverage single-cell mRNA sequencing reveals cellular heterogeneity and activated signaling pathways in developing cerebral cortex.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 10, p. 1053, doi. 10.1038/nbt.2967
- By:
- Publication type:
- Article
Biopharmaceutical benchmarks 2014.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 10, p. 992, doi. 10.1038/nbt.3040
- By:
- Publication type:
- Article
Bridging the gap between invention and commercialization in medical devices.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 10, p. 1063, doi. 10.1038/nbt.3041
- By:
- Publication type:
- Article
Second MRSA antibiotic reaches the market.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 10, p. 972, doi. 10.1038/nbt1014-972
- By:
- Publication type:
- Article
Actionable Genome Consortium to guide NGS in cancer.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 10, p. 965, doi. 10.1038/nbt1014-965d
- Publication type:
- Article
Vertex buries Incivek.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 10, p. 966, doi. 10.1038/nbt1014-966b
- Publication type:
- Article
Enzyme clustering accelerates processing of intermediates through metabolic channeling.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 10, p. 1011, doi. 10.1038/nbt.3018
- By:
- Publication type:
- Article
Electric Grand Prix cars to be powered by algae-based generators.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 10, p. 965, doi. 10.1038/nbt1014-965b
- Publication type:
- Article
The price of priority review: $67.5 million.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 10, p. 973, doi. 10.1038/nbt1014-973
- By:
- Publication type:
- Article
First PI3k inhibitor launches into crowded hematology markets.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 10, p. 963, doi. 10.1038/nbt1014-963
- By:
- Publication type:
- Article
Miniaturizing wireless implants.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 10, p. 1008, doi. 10.1038/nbt.3038
- By:
- Publication type:
- Article
A blueprint of cell identity.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 10, p. 1007, doi. 10.1038/nbt.3035
- By:
- Publication type:
- Article
Nature's contribution to today's pharmacopeia.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 10, p. 979, doi. 10.1038/nbt.3034
- By:
- Publication type:
- Article
NIH issues genomic data sharing policy.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 10, p. 966, doi. 10.1038/nbt1014-966a
- Publication type:
- Article
De novo assembly of soybean wild relatives for pan-genome analysis of diversity and agronomic traits.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 10, p. 1045, doi. 10.1038/nbt.2979
- By:
- Publication type:
- Article